← Open Payments lookup

SAMANTHA DAVIS: Open Payments

NPI 1801231931 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$600 in 22 payments from 7 companies in 2025. Trend: 2023 $156 · 2024 $436 · 2025 $600

Food & beverage: $557Education: $43
CompanyPaymentsAmount
Merck Sharp & Dohme LLC9$248
Eisai Inc.7$192
AstraZeneca Pharmaceuticals LP1$43
Janssen Biotech, Inc.2$40
Corcept Therapeutics1$29
Sumitomo Pharma America, Inc.1$28
ConvaTec Inc.1$20

Products named: Lenvima, KEYTRUDA, LYNPARZA, ENHERTU, ERLEADA, Korlym, ORGOVYX, KEYTRUDA QLEX.

Industry payments across IN — which companies pay providers there.